» Articles » PMID: 32924832

Prevalence and Incidence of Systemic Lupus Erythematosus in Tucumán, Argentina

Abstract

Methods: The study included inpatient and outpatient charts from four public hospitals and private practice rheumatology clinics, all of them members of the Tucumán Rheumatology Society. Patients older than 16 years with diagnosis of SLE between January 2005 and December 2012 were included. Prevalence and annual incidence were calculated as the number of cases per 100.000 inhabitants during the period 2005 to 2012.

Results: Three hundred fifty-three patients were identified. The mean age at diagnosis was 30.5 ± 11.7 years, 93.5% women, 83% mestizos. Prevalence was 24.3 cases/100.000 inhabitants (CI 95% 22.6-28.8) and age-adjusted (≥16 years) of 34.9 cases/100.000 inhabitants (CI 95% 32.8-41.1). The annual incidence in 2005 was 1.8 cases/100.000 inhabitants (95% CI 1-2.9) and 2012 of 4.2 cases/100.000 inhabitants (95% CI 2.9-5.8). Mortality was 9.1%, with infections being the most frequent cause (14/32).

Conclusion: The prevalence of SLE in the province of Tucumán was 34.9 cases/100.000 inhabitants.

Citing Articles

Current investigation of the high prevalence of sexual dysfunction in female patients with systemic lupus erythematosus: a cross-sectional study.

Xia X, Liu S, Song Z, Chen P, Hu J, Zhao W Rheumatol Int. 2024; 44(10):2147-2157.

PMID: 39153077 DOI: 10.1007/s00296-024-05690-6.


Infections in Patients with Systemic Lupus Erythematosus: The Contribution of Primary Immune Defects Versus Treatment-Induced Immunosuppression.

Kunzler A, Tsokos G Eur J Rheumatol. 2023; 10(4):148-158.

PMID: 37850609 PMC: 10765185. DOI: 10.5152/eurjrheum.2023.23068.


Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus.

Ugarte-Gil M, Fuentes-Silva Y, Pimentel-Quiroz V, Pons-Estel G, Quintana R, Pons-Estel B Front Med (Lausanne). 2023; 9:988191.

PMID: 36714141 PMC: 9874001. DOI: 10.3389/fmed.2022.988191.


Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis.

Fatoye F, Gebrye T, Mbada C Rheumatol Int. 2022; 42(12):2097-2107.

PMID: 36006459 PMC: 9548466. DOI: 10.1007/s00296-022-05183-4.


Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts.

Moe S, Haukeland H, Molberg O, Lerang K J Clin Med. 2021; 10(19).

PMID: 34640322 PMC: 8509465. DOI: 10.3390/jcm10194306.